Algorae Pharmaceuticals Ltd (LVCLY)
0.0246
-0.01
(-17.73%)
USD |
OTCM |
May 17, 16:00
Algorae Pharmaceuticals 1 Year Total Returns (Daily): -27.00% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -27.00% |
May 16, 2024 | -33.33% |
May 15, 2024 | -33.33% |
May 14, 2024 | -33.33% |
May 13, 2024 | -44.26% |
May 10, 2024 | -44.26% |
May 09, 2024 | -44.26% |
May 08, 2024 | -1.43% |
May 07, 2024 | -1.43% |
May 06, 2024 | -1.43% |
May 03, 2024 | -1.43% |
May 02, 2024 | -1.43% |
May 01, 2024 | -1.43% |
April 30, 2024 | -1.43% |
April 29, 2024 | -1.43% |
April 26, 2024 | -1.43% |
April 25, 2024 | -3.66% |
April 24, 2024 | -3.66% |
April 23, 2024 | -17.86% |
April 22, 2024 | -17.86% |
April 19, 2024 | -14.29% |
April 18, 2024 | -14.29% |
April 17, 2024 | -14.29% |
April 16, 2024 | -14.29% |
April 15, 2024 | -14.29% |
Date | Value |
---|---|
April 12, 2024 | -21.43% |
April 11, 2024 | -18.04% |
April 10, 2024 | -18.04% |
April 09, 2024 | -18.04% |
April 08, 2024 | -37.86% |
April 05, 2024 | -26.46% |
April 04, 2024 | -26.46% |
April 03, 2024 | -26.46% |
April 02, 2024 | 11.54% |
April 01, 2024 | -22.76% |
March 28, 2024 | -46.56% |
March 27, 2024 | -46.56% |
March 26, 2024 | -44.74% |
March 25, 2024 | -44.74% |
March 22, 2024 | -43.24% |
March 21, 2024 | -71.62% |
March 20, 2024 | -71.62% |
March 19, 2024 | -71.62% |
March 18, 2024 | -71.62% |
March 15, 2024 | -23.18% |
March 14, 2024 | -23.18% |
March 13, 2024 | -23.18% |
March 12, 2024 | -23.18% |
March 11, 2024 | -23.18% |
March 08, 2024 | -48.70% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.30%
Minimum
Mar 11 2022
221.2%
Maximum
Jul 31 2023
-15.03%
Average
-21.82%
Median
Dec 21 2023
1 Year Total Returns (Daily) Benchmarks
Alterity Therapeutics Ltd | -31.03% |
Kazia Therapeutics Ltd | -77.95% |
Immutep Ltd | 12.98% |
Opthea Ltd | -10.73% |
Mesoblast Ltd | -3.80% |